Kobe, Japan

Masayo Fujiwara

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayo Fujiwara. Retrieved from https://idiyas.com/inventor/masayo-fujiwara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Masayo Fujiwara: Advancements in iPS Cell Technology

Introduction: Masayo Fujiwara is a notable inventor based in Kobe, Japan, who has made significant contributions to the field of regenerative medicine. With her innovative thinking and expertise, she has developed technologies that pave the way for advancements in cell therapy and cancer treatment.

Latest Patents: Masayo Fujiwara holds a patent for her invention titled "Agent for removing undifferentiated iPS cells." This patent describes a compound that has an inhibitory effect on the sphere-forming ability of cancer cells, making it a valuable agent for removing induced pluripotent stem (iPS) cells. The compound is characterized by a specific chemical formula, which includes a range of possible substitutions. This invention has important implications for improving therapeutic strategies in cancer treatment.

Career Highlights: Currently, Masayo Fujiwara is associated with Sumitomo Pharma Co., Ltd., a well-respected company known for its research and development in pharmaceuticals. Her work at the company encompasses research that aims to improve the efficacy and safety of treatments involving iPS cells.

Collaborations: Throughout her career, Masayo has collaborated with talented professionals such as Yasushi Hiramine and Hitoshi Ban. These collaborations have enriched her research, leading to innovative solutions and insights in the field of cell biology and regenerative medicine.

Conclusion: Masayo Fujiwara exemplifies the spirit of innovation in the scientific community. With her groundbreaking patent and collaboration with key researchers, she is poised to make lasting contributions to the understanding and application of iPS cells, ultimately benefiting patients and advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…